Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Senate Moves To Floor Phase For Innovation Bill; Postmarket Surveillance, LDTs Could Get Attention

This article was originally published in The Gray Sheet

Executive Summary

The Senate HELP Committee passed more measures for its planned medical innovation bill, including one affecting FDA's issuance of guidances versus formal rulemaking, and another in support of the administration's Precision Medicine initiative at an April 6 markup. Leadership also promised later floor debate on laboratory-developed test regulations and a device postmarket surveillance bill.


Related Content

House Set To Vote On Cures Nov. 30; Latest Version Includes 510(k)s In Breakthrough Pathway
Quest For Political Capital, Legacy Could Push 'Cures' Over The Finish Line
Industry Urges Caution In Response To Growing Push For 'Real-World' Device Evaluation System
Party Leaders, Former St. Jude Exec Lead In Medtech Campaign Donations
Innovation Bill Scorecard: Device, Diagnostic Provisions In Senate And House
Lab Group Urges FDA To Wait For Congress On LDT Issue
Lab Group Urges FDA To Wait For Congress On LDT Issue
Senate Panel Passes Breakthrough Device, Other Measures; FDA Funding Debated





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts